Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,562 across all filing types
Latest filing 2026-05-25 Notice of Dividend Amou…
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
公告本公司現金股利發放公告
Notice of Dividend Amount Classification · 93% confidence The document is a corporate announcement titled “公告本公司現金股利發放公告” which provides the declaration of cash dividend amounts, ex-dividend dates, record dates, and payment dates. This clearly matches the definition of a Notice of Dividend Amount (DIV).
2026-05-25 Chinese
公告本公司股東常會通過解除董事及其代表人競業禁止之限制
Declaration of Voting Results & Voting Rights Announcements Classification · 88% confidence The document is a disclosure from the public information observatory for a Taiwanese listed company, summarizing the shareholder meeting resolution held on 115/05/25. It details the vote outcome (“出席股東表決權三分之二以上表決同意”) regarding lifting the non-compete restriction for certain directors. This is a clear report of voting results from a general meeting, matching Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-25 Chinese
公告本公司115年股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an official announcement by the listed company of the resolutions passed at the 115th annual general meeting of shareholders, including profit distribution, approval of the business report and financial statements, and other AGM voting outcomes. This corresponds to a Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-25 Chinese
本公司檸檬酸鐵原料藥上市登記進口案獲中國國家 藥監局核准
Regulatory Filings Classification · 90% confidence The document is a regulatory disclosure on the Taiwan Public Information Observatory by listed company 1760 寶齡富錦 announcing that its active pharmaceutical ingredient (ferric citrate) has been approved for registration by China’s NMPA. It provides factual event date, company relationship, background, and significance. It is not a full financial report or presentation but a general material event announcement, placing it in the fallback category for miscellaneous regulatory filings: RNS.
2026-05-21 Chinese
115年第1季財務報告書 — 202601_1760_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled “合併財務報告暨會計師核閱報告” for 民國一一五年及一一四年第一季 and includes a full accountants’ review report plus consolidated balance sheet, income statement, cash flow, statement of changes, and extensive notes. It contains actual financial statements for the quarter rather than merely announcing or linking to a report. This matches the definition of an interim/quarterly report. Q1 2026
2026-05-13 Chinese
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 85% confidence The document is a Taiwanese public disclosure (“公開資訊觀測站”) titled “115年1季申報作業,” which translates to the first quarter reporting operations. It contains detailed financial data—investment balances, original investment amounts, and recognized profit or loss for the quarter—rather than merely announcing availability of a report. This is substantive quarterly financial information, consistent with an Interim/Quarterly Report (IR). Q1 2026
2026-05-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.